These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 144224)

  • 1. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of acute acoustic trauma (blast injury) with dextran 40 (author's transl)].
    Jakobs P; Martin G
    HNO; 1977 Oct; 25(10):349-52. PubMed ID: 914661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantinol nicotinate.
    Gruber UF; Duckert F; Fridrich R; Torhorst J; Rem J
    Lancet; 1977 Jan; 1(8005):207-10. PubMed ID: 64746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute inner ear deafness (sudden deafness and acoustic trauma) (author's transl)].
    Kellerhals B
    Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):357-63. PubMed ID: 140984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapy of tinnitus resulting from blast injury (author's transl)].
    Jakobs P; Martin G
    HNO; 1978 Mar; 26(3):104-6. PubMed ID: 346541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H; Lehmann E
    Arzneimittelforschung; 1978; 28(9):1531-2. PubMed ID: 582552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xantinol nicotinate in paralytic poliomyelitis.
    Saksena PN; Malik GK; Tandon OP
    Indian Pediatr; 1979 Dec; 16(12):1081-4. PubMed ID: 541073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and structure determination of metabolites of xantinol from rat urine (author's transl)].
    Tauscher M; Eckhardt G; Geisel B; Credner K
    Arzneimittelforschung; 1976; 26(7):1342-4. PubMed ID: 1036921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT; Saling E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):283-9. PubMed ID: 7008399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of hardness of hearing with origin in the inner ear by means of Xavin.
    Révész G; Ribári O; Zelen B; Stanzel G
    Ther Hung; 1977; 25(2):64-8. PubMed ID: 898120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sympathetic trunk treatment or infusion therapy in cases of sudden deafness (author's transl)].
    Strauss P; Kunkel A
    Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):366-71. PubMed ID: 140986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of sudden hearing loss as a clinical problem (author's transl)].
    Knothe J
    HNO; 1979 May; 27(5):159-64. PubMed ID: 457458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of sudden deafness with xantinolnicotinate (Complamin) in increasing dosage].
    Halevy A; Strohm G; Wieczorek U
    HNO; 1986 Jul; 34(7):285-90. PubMed ID: 3744912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of xanthinol nicotinate on brain metabolism in rats].
    Brenner G
    Arzneimittelforschung; 1983; 33(5):698-701. PubMed ID: 6683547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of a combination of rheopolyglucin, complamin and trental in the complex treatment of acute postoperative pancreatitis].
    Lupal'tsev VI
    Klin Khir (1962); 1988; (11):27-9. PubMed ID: 2464717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.